| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,151,963 ) |
| | 2023 | 2023 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 001 | 5 | NIH | 9/28/2023 | $0 |
| | 2023 | 2023 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 000 | 5 | NIH | 6/15/2023 | $1,151,963 |
|
| Issue Date FY: 2022 ( Subtotal = $1,163,856 ) |
| | 2022 | 2022 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 001 | 4 | NIH | 7/5/2022 | $1,163,856 |
| | 2022 | 2022 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 002 | 4 | NIH | 9/21/2022 | $0 |
| | 2022 | 2021 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 000 | 3 | NIH | 11/9/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,186,732 ) |
| | 2021 | 2021 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 001 | 3 | NIH | 6/30/2021 | $1,233,319 |
| | 2021 | 2020 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 000 | 2 | NIH | 11/10/2020 | $0 |
| | 2021 | 2019 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | R42DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | 001 | 3 | NIH | 9/1/2021 | -$46,587 |
| | 2021 | 2018 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | R42DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | 000 | 3 | NIH | 7/12/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,259,901 ) |
| | 2020 | 2020 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 001 | 2 | NIH | 7/22/2020 | $1,259,901 |
| | 2020 | 2019 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 000 | 1 | NIH | 7/22/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,500,277 ) |
| | 2019 | 2019 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | R42DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | 000 | 3 | NIH | 9/14/2019 | $206,585 |
| | 2019 | 2019 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | U01AA027997 | Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder | 000 | 1 | NIH | 9/20/2019 | $1,293,692 |
|
| Issue Date FY: 2018 ( Subtotal = $769,627 ) |
| | 2018 | 2018 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | R42DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | 001 | 3 | NIH | 9/1/2018 | $769,627 |
| | 2018 | 2017 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | R42DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | 000 | 2 | NIH | 1/25/2018 | $42,183 |
| | 2018 | 2015 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | R41DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibiton for Obesity | 000 | 1 | NIH | 1/25/2018 | -$42,183 |
|
| Issue Date FY: 2017 ( Subtotal = $289,373 ) |
| | 2017 | 2017 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016-4718 | ARAPAHOE | USA | R42DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | 000 | 2 | NIH | 9/15/2017 | $289,373 |
|
| Issue Date FY: 2015 ( Subtotal = $183,693 ) |
| | 2015 | 2015 | COLORADO RESEARCH PARTNERS LLC | 15857 E ABERDEEN AVE | CENTENNIAL | CO | 80016 | ARAPAHOE | USA | R41DK104432 | Scientific Merit and Feasibility of Fructokinase Inhibiton for Obesity | 000 | 1 | NIH | 9/15/2015 | $183,693 |
|
|
